HOME >> BIOLOGY >> NEWS
16th EORTC NCI AACR Symposium

The revolution in understanding the molecular basis of cancer has lead to the discovery and development of numerous innovative agents 'designer' diagnostics, new prognostic tests, 'smart' drugs and other entirely novel ways of tackling cancer.

To bring these new developments to patients as quickly and efficiently as possible requires international collaboration, early and optimal exchange of information, good quality translational research, efficient drug development and large prospective clinical trials.

Three of the world's leading cancer organisations:

  • The European Organisation for Research and Treatment of Cancer;
  • The USA's National Cancer Institute;
  • The American Association for Cancer Research;

    will join forces in Geneva from 28 September to 1 October to provide a platform for presentation of the latest findings in drug research and development to around 2,000 international experts in the field.

    All data at the four-day meeting are being presented for the first time.

    We welcome the media to the symposium. Every session is open to journalists and registration is free to bona fide media presenting official press credentials, or a letter from the editor of the journal they represent stating that they are being commissioned to write a report for publication.

    A media centre with computing, fax, photocopying and free international phone and internet connections will be available.

    NB: the official language of the symposium is English and all press materials will be in English.

    To register: contact Margaret Willson for a registration form or download one from the conference website.


    '"/>



  • Contact: Margaret Willson
    m.willson@mwcommunications.org.uk
    44-015-367-72181
    European Organisation for Research and Treatment of Cancer
    19-Jul-2004


    Page: 1

    Related biology news :

    1. 16th EORTC NCI AACR Symposium Molecular Targets and Cancer Therapeutics
    2. 16th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
    3. Final Alert: 16th EORTC NCI AACR Symposium
    4. Clock cells, tumor suicide, tailored therapies among subjects of AACR-NCI-EORTC Conference
    5. 14th EORTC NCI AACR Symposium
    6. Environmental issues center of Inland Northwest Research Alliance 4th Annual Symposium
    7. Health of worlds sea lions the focus of Wakefield Symposium
    8. Chemical signals health of brain cells Symposium
    9. Symposium to tackle questions of genetic engineering and biodiversity
    10. Fostering Diversity in the Sciences Symposium
    11. Annual Chemical Biology Symposium at Yale May 14, 2004

    Post Your Comments:
    *Name:
    *Comment:
    *Email:


    (Date:8/14/2019)... and MARTINSRIED, Germany (PRWEB) , ... August 14, ... ... antibody screening and characterization, announced today that they have opened a Customer Experience ... has fueled the need for the new office. , The Munich CEC will ...
    (Date:8/14/2019)... Calif. (PRWEB) , ... August 13, 2019 , ... Dr. Julie Reck of Veterinary ... to her patients. Her first stem cell patient, her own geriatric Australian Shepherd, ... According to Dr. Reck, Simon wanted to play but his body was weak, and he ...
    (Date:8/6/2019)... ... 2019 , ... Rigaku Corporation , a global leader ... & Microanalysis 2019 Meeting ( M&M 2019 ), taking place August 4 - ... & Microanalysis Meeting, organized by the Microscopy Society of America, is the world’s ...
    Breaking Biology News(10 mins):
    (Date:7/17/2019)... N.J. (PRWEB) , ... July ... ... announced a long-term strategic agreement for the development and manufacturing of Zolgensma® ... , Through this collaboration, AveXis, a Novartis company, will have dedicated manufacturing ...
    (Date:7/2/2019)... ... ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma , was recently featured in ... on regenerative veterinary medicine as a means of improving the quality of life for ... Brentwood and Pacific Palisades International Film Festival in Los Angeles, California where it received ...
    (Date:6/11/2019)... ... June 10, 2019 , ... ... distribution network with the appointment of Biofeedback Tech Ltd as its ... are an essential part of many therapeutic treatments and clinical assessment protocols to ...
    (Date:6/11/2019)... ... June 11, 2019 , ... ... human mesenchymal stem cells (MSC-EV) are able to incorporate into human CD34+ cells, ... test on mice, MSC-EVs also increased the cells’ ability to lodge into bone ...
    Breaking Biology Technology:
    Cached News: